These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6218211)

  • 41. T-B collaboration in the in vitro anti-Sm autoantibody response of MRL/Mp-lpr/lpr mice.
    Shores EW; Eisenberg RA; Cohen PL
    J Immunol; 1988 May; 140(9):2977-82. PubMed ID: 2966204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Role of antilymphocytic antibodies in the pathogenesis of systemic lupus erythematosus].
    Gliński W
    Przegl Dermatol; 1976; 63(5):699-705. PubMed ID: 1087422
    [No Abstract]   [Full Text] [Related]  

  • 43. B cell activity and regulatory T cell function in systemic lupus erythematosus by human B cell colony formation.
    Otsuka T; Okamura S; Niho Y; Kusaba T
    J Rheumatol; 1985 Jun; 12(3):508-13. PubMed ID: 2864442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Suppressor hyperactivity in relation to allogeneic lymphocyte proliferation as a manifestation of T- T-cell interaction defects in systemic lupus erythematosus].
    Stenina MA; Potapova AA; Biriukov AV; Skripnik AIu; Cheredeev AH
    Biull Eksp Biol Med; 1986 Aug; 102(8):215-7. PubMed ID: 2874848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunological abnormalities in multiple sclerosis].
    Tabira T
    No To Shinkei; 1983 Jun; 35(6):535-41. PubMed ID: 6194805
    [No Abstract]   [Full Text] [Related]  

  • 46. [Function and significance of B-lymphocyte defects in the pathogenesis of systemic lupus erythematosus].
    Wollina U
    Dermatol Monatsschr; 1984; 170(2):81-90. PubMed ID: 6202566
    [No Abstract]   [Full Text] [Related]  

  • 47. Allogeneic suppression of polyclonal immunoglobulin production in normals and patients with systemic lupus erythematosus.
    Clough JD; Krakauer RA; Frank SA; Calabrese LH
    Clin Exp Immunol; 1980 Oct; 42(1):27-32. PubMed ID: 6450653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells.
    Sakane T; Takada S; Suzuki N; Tsuchida T; Murakawa Y; Ueda Y
    J Immunol; 1986 Dec; 137(12):3809-13. PubMed ID: 2946769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [B-cell anomalies in systemic lupus erythematosus].
    Tron F; Jacquot S; Gilbert D
    Ann Med Interne (Paris); 2002 Dec; 153(8):503-12. PubMed ID: 12610424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of plasmapheresis on T anc B lymphocyte functions in patients with systemic lupus erythematosus: a double blind study.
    Tsokos GC; Balow JE; Huston DP; Wei N; Decker JL
    Clin Exp Immunol; 1982 May; 48(2):449-57. PubMed ID: 6213330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics of anti-T-cell antibodies in systemic lupus erythematosus: evidence for selective reactivity with normal suppressor cells defined by monoclonal antibodies.
    Morimoto C; Reinherz EL; Abe T; Homma M; Schlossman SF
    Clin Immunol Immunopathol; 1980 Aug; 16(4):474-84. PubMed ID: 6447557
    [No Abstract]   [Full Text] [Related]  

  • 52. [Autologous mixed lymphocyte reaction in systemic lupus erythematosus].
    Chang ZN; Tsai LC; Chang LD; Lan JL; Han SH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Nov; 18(4):240-6. PubMed ID: 2935373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic and immune aspects of systemic lupus erythematosus.
    Taurog JD; Steinberg AD
    Int J Dermatol; 1981 Apr; 20(3):149-58. PubMed ID: 6456240
    [No Abstract]   [Full Text] [Related]  

  • 54. Lymphocytes and lymphocyte functions in systemic lupus erythematosus.
    Raveche ES; Steinberg AD
    Semin Hematol; 1979 Oct; 16(4):344-70. PubMed ID: 159489
    [No Abstract]   [Full Text] [Related]  

  • 55. Mixed connective tissue disease: a disorder of immune regulation.
    Alarcón-Segovia D
    Semin Arthritis Rheum; 1983 Aug; 13(1 Suppl 1):114-20. PubMed ID: 6226095
    [No Abstract]   [Full Text] [Related]  

  • 56. Inhibition of proliferative and suppressor responses in the autologous mixed lymphocyte reaction by serum from patients with systemic lupus erythematosus.
    Stephens HA; Fitzharris P; Knight RA; Snaith ML
    Ann Rheum Dis; 1982 Oct; 41(5):495-501. PubMed ID: 6215003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NIH conference. Systemic lupus erythematosus: evolving concepts.
    Decker JL; Steinberg AD; Reinertsen JL; Plotz PH; Balow JE; Klippel JH
    Ann Intern Med; 1979 Oct; 91(4):587-604. PubMed ID: 158324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppressor cell function defect in idiopathic systemic lupus erythematosus.
    Krakauer RS; Clough JD; Frank S; Sundeen JT
    Clin Immunol Immunopathol; 1979 Nov; 14(3):327-33. PubMed ID: 159148
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies of immune functions of patients with systemic lupus erythematosus. V. T cell suppressor function and autologous mixed lymphocyte reaction during active and inactive phases of disease.
    Sakane T; Steinberg AD; Green I
    Arthritis Rheum; 1980 Feb; 23(2):225-31. PubMed ID: 6444818
    [No Abstract]   [Full Text] [Related]  

  • 60. Systemic lupus erythematosus in 2015: Cellular and metabolic requirements of effector T cells.
    Tsokos GC
    Nat Rev Rheumatol; 2016 Feb; 12(2):74-6. PubMed ID: 26729463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.